Alere and Abbott End Mediation Without Settlement | GenomeWeb

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Alere said that mediation between itself and Abbott Laboratories has concluded without resolution. 

Alere sued Abbott in August in a move designed to push its potential acquirer to fulfill its obligations under the terms of their merger agreement, and act promptly in obtaining the required anti-trust approvals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.